MNPR - Monopar Therapeutics

QQQ $ 598.50 $ -4.01 (-0.67 %)

DIA $ 463.08 $ 2.03 (0.44 %)

SPY $ 662.74 $ -0.81 (-0.12 %)

TLT $ 90.69 $ 0.29 (0.32 %)

GLD $ 382.95 $ 2.70 (0.71 %)

Previous Close

$ 95.29

Open

$ 101.95

Bid

$ 93.49 x 1

Ask

$ 102.15 x 101

Day's Range

-- - --

52 Week Range

$ 4.50 - $ 105.00

Volume

63,211

Average Volume

Market Cap

587.94M

Beta (5Y Monthly)

$ 0.72

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	03-31-2025	12-31-2024	10-K
4	11-08-2024	09-30-2024	10-Q
5	08-09-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-28-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-11-2023	03-31-2023	10-Q
11	03-23-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-12-2022	03-31-2022	10-Q
15	03-24-2022	12-31-2021	10-K
16	11-12-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	03-25-2021	12-31-2020	10-K
20	11-12-2020	09-30-2020	10-Q
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-27-2020	12-31-2019	10-K
24	11-12-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-10-2019	03-31-2019	10-Q
27	02-26-2019	12-31-2018	10-K
28	11-09-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-11-2018	03-31-2018	10-Q
31	03-26-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

this-monopar-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday

This Monopar Therapeutics Analyst Begins C...
10/13/2025 12:25:51

Barclays Initiates Coverage On Monopar The...
10/13/2025 12:05:47

Barclays analyst Etzer Darout initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Overweight rating and announce...

Raymond James Maintains Strong Buy on Mono...
10/06/2025 16:59:18

Raymond James analyst Chris Raymond maintains Monopar Therapeutics (NASDAQ:MNPR) with a Strong Buy and raises the price targ...

Oppenheimer Maintains Outperform on Monopa...
10/02/2025 13:31:55

Oppenheimer analyst Andreas Argyrides maintains Monopar Therapeutics (NASDAQ:MNPR) with a Outperform and raises the price ta...

HC Wainwright & Co. Maintains Buy on Monop...
09/29/2025 14:09:37

HC Wainwright & Co. analyst Andres Y. Maldonado maintains Monopar Therapeutics (NASDAQ: MNPR) with a Buy and raises the ...

Piper Sandler Maintains Overweight on Mono...
09/25/2025 16:52:30

Piper Sandler analyst Biren Amin maintains Monopar Therapeutics (NASDAQ: MNPR) with a Overweight and raises the price target...

crowdstrike-to-rally-around-26-here-are-10-top-analyst-forecasts-for-thursday

CrowdStrike To Rally Around 26%? Here Are ...
09/25/2025 12:16:13

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

BTIG Maintains Buy on Monopar Therapeutics...
09/25/2025 11:56:35

BTIG analyst Jeet Mukherjee maintains Monopar Therapeutics (NASDAQ: MNPR) with a Buy and raises the price target from $87 t...

Chardan Capital Maintains Buy on Monopar T...
09/25/2025 11:52:13

Chardan Capital analyst Keay Nakae maintains Monopar Therapeutics (NASDAQ: MNPR) with a Buy and raises the price target from...

Reported Earlier ,Monopar Highlights Journ...
09/24/2025 06:25:51

Reported Earlier, Monopar Therapeutics Pri...
09/24/2025 06:25:09

Lake Street Initiates Coverage On Monopar ...
09/23/2025 14:38:19

Lake Street initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Buy rating and announces Price Target of $106.

Chardan Capital Maintains Buy on Monopar T...
09/16/2025 11:11:37

Chardan Capital analyst Keay Nakae maintains Monopar Therapeutics (NASDAQ:MNPR) with a Buy and maintains $60 price target.

BTIG Reiterates Buy on Monopar Therapeutic...
09/15/2025 14:41:09

BTIG analyst Jeet Mukherjee reiterates Monopar Therapeutics (NASDAQ:MNPR) with a Buy and maintains $87 price target.

Monopar To Present 6-Year Data Showing Sus...
09/14/2025 12:15:57

Monopar Therapeutics Inc. (NASDAQ:MNPR) announced that new data on the long-term neurological efficacy and safety of its invest...

BTIG Initiates Coverage On Monopar Therape...
09/09/2025 10:50:39

BTIG analyst Jeet Mukherjee initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Buy rating and announces Price ...

Raymond James Initiates Coverage On Monopa...
09/03/2025 16:49:58

Raymond James analyst Chris Raymond initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Strong Buy rating and an...

Oppenheimer Initiates Coverage On Monopar ...
09/03/2025 16:39:09

Oppenheimer analyst Andreas Argyrides initiates coverage on Monopar Therapeutics (NASDAQ:MNPR) with a Outperform rating and ...

Monopar Therapeutics Files For Mixed Shelf...
08/29/2025 20:43:53

-SEC Filing

Cantor Fitzgerald Reiterates Overweight on...
08/27/2025 13:16:54

Cantor Fitzgerald analyst Kristen Kluska reiterates Monopar Therapeutics (NASDAQ:MNPR) with a Overweight and maintains $74 p...